NCT06103227 is a Phase 2, PHASE3 clinical trial of Prednisone 5Mg in Preterm Birth, sponsored by University of Mostar.

Who is sponsoring NCT06103227?

NCT06103227 is sponsored by University of Mostar.

What drugs are being tested in NCT06103227?

Interventions in NCT06103227: Prednisone 5Mg.

What condition does NCT06103227 study?

NCT06103227 studies Preterm Birth.

Is NCT06103227 still recruiting?

NCT06103227 is currently completed. Last updated 19 February 2025.

Last reviewed 2025-02-19 · How we verify

NCT06103227

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Effect of Low Doses of Prednisone on the Prolongation of Pregnancy in Threatened Preterm Birth

Completed Phase 2, PHASE3 Last updated 19 February 2025

What this trial tests

Phase 2, PHASE3 trial testing Prednisone 5Mg in Preterm Birth in 26 participants. Completed in 2 December 2024.

Timeline

8 November 2023

Primary endpoint
25 November 2024

2 December 2024

Quick facts

Lead sponsor	University of Mostar
Phase	Phase 2, PHASE3
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	26
Start date	8 November 2023
Primary completion	25 November 2024
Estimated completion	2 December 2024
Sites	1 location across Bosnia and Herzegovina

Drugs / interventions tested

Prednisone 5Mg

Conditions studied

Preterm Birth — all drugs for Preterm Birth →

Sponsor

University of Mostar

Who can join

Adults 18 to 50, female only, with Preterm Birth. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this clinical trial is to test the effect of a low dose of prednisone in the prevention of preterm labour in singleton pregnancies. The main question it aims to answer is whether prednisone prolongs singleton pregnancy in threatened preterm birth and reduces mortality and morbidity of newborns without harmful consequences for the mother and the foetus. Participants will be: * administered low dose of prednisone in a period of a total of 3 weeks on top of standard therapy * drown blood for standard laboratory tests * cervical swab and urine for urine culture will be taken, and * asked to sign Informed Consent The researcher will compare a low dose of prednisone to standard therapy.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Prednisone 5Mg

Trials testing the same drug.

NCT03263650 — Study of Olaparib Maintenance Following Cabazitaxel-Carbo in Men With AVPC · Phase 2 · active not recruiting

Other recruiting trials for Preterm Birth

Currently open trials in the same condition.

NCT07265583 — Early Prediction of Lung Injury in Preterm Infants Score · recruiting
NCT07305935 — Comparison of Early Caffeine Administration Vs Supportive Therapy in Preventing Acute Kidney Injury · NA · recruiting
NCT07192393 — Health-Related Quality-of-Life and Household Financial and Wellbeing Impacts of Prematurity and Necrotising Enterocoliti · recruiting
NCT06826859 — Daily Aspirin vs Split Dosing in High-risk Pregnancies (DASH) · Phase 1, PHASE2 · recruiting
NCT07231432 — Promoting Kangaroo Care for Preterm or Low Birthweight Infants in Rural India · NA · active not recruiting

Other University of Mostar trials

Trials by the same sponsor.

NCT07236424 — Effectiveness of Exercise, Walking, and Education on Mental Health, Mobility and Quality of Life in Elderly Residents of · NA · completed
NCT07100795 — Vitamin B12, Folic Acid and Vitamin D Status in Women of Reproductive Age · recruiting
NCT07099586 — Vitamin B12, Folic Acid, and Vitamin D Status in Women of Reproductive Age · recruiting
NCT07085013 — Effectiveness of Personalized Oral Hygiene Education in Medical and Dental Students Over Two Years · NA · completed
NCT05479565 — Relationship of Reduced Arterial Stiffness and Hs-CRP With GDM. · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06103227 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Mostar
Last refreshed: 19 February 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06103227.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing